Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose and Probiotics for Diabetic Constipation
NCT07065942Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2023
- Primary completion
- Jul 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, open-label trial of Medilac-S in functional constipation (FC) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Changes in Constipation Symptom Scores Pre- and Post-Treatment at 4 weeks, Changes in Fecal Microbiota Composition (16S rRNA and Metagenomics) at 4 weeks and 1 more. Started Jul 2023; status: recruiting.
02
Drugs
Medilac-S
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on NCT07065942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07065942.